Envestnet Asset Management
AGN

Envestnet Asset Management’s Allergan Inc AGN Stock Holding History

Envestnet Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,424
Closed -$303K – 2734
2014
Q4 		$303K Sell
1,424
-1,172
-45% -$233K ﹤0.01% 873
2014
Q3 		$463K Buy
2,596
+633
+32% +$105K ﹤0.01% 809
2014
Q2 		$332K Sell
1,963
-2,508
-56% -$390K ﹤0.01% 864
2014
Q1 		$555K Buy
4,471
+366
+9% +$44.6K 0.01% 628
2013
Q4 		$456K Buy
4,105
+361
+10% +$34.5K 0.01% 645
2013
Q3 		$339K Sell
3,744
-4,761
-56% -$427K ﹤0.01% 694
2013
Q2 		$716K Buy
+8,505
New +$882K 0.01% 478

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Envestnet Asset Management's AGN Position: Q1 2015 in Review

Envestnet Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,424 shares — an estimated $303K sold.

Envestnet Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $716K in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Envestnet Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Envestnet Asset Management sold 1,424 Allergan Inc shares in Q1 2015, an estimated $303K.
  • Envestnet Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Envestnet Asset Management's Allergan Inc position peaked at $716K in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Envestnet Asset Management's 13F filing for Q1 2015, filed 15 May 2015.